Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease

Nephrology Dialysis Transplantation

Volumn 25, Issue 7, 2010, Pages 2265-2272

  Ulrich, Christof ^a   Heine, Gunnar H ^b   Seibert, Eric ^a   Fliser, Danilo ^b   Girndt, Matthias ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

angiotensin converting enzyme; antigens, CD16; atherosclerosis; kidney failure chronic; monocytes

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; CD14 ANTIGEN; CD16 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; BIOLOGICAL MARKER; FC RECEPTOR;

ADULT; AGE DISTRIBUTION; ALBUMIN BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CELL SUBPOPULATION; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HEMODIALYSIS; HUMAN; HUMAN CELL; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MORTALITY; OBSERVATIONAL STUDY; PERITONEAL DIALYSIS; PILOT STUDY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; AGED; BLOOD; CHRONIC KIDNEY FAILURE; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE; PROGNOSIS;

AGED; ANTIGENS, CD14; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MONOCYTES; PEPTIDYL-DIPEPTIDASE A; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, IGG;

EID: 77954343729     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq012     Document Type: Article

References (25)

1. Cheung AK, Sarnak MJ, Yan G et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000; 58: 353-362
2. Zimmermann J, Herrlinger S, Pruy A et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648-658
3. Tripepi G, Mallamaci F, Zoccali C. Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. J Am Soc Nephrol 2005; 16: S83-S88
4. Bologa RM, Levine DM, Parker TS et al. Interleukin-6 predicts hy-poalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 1998; 32: 107-114
5. Sester U, Sester M, Heine G et al. Strong depletion of CD14(+)CD16 (+) monocytes during haemodialysis treatment. Nephrol Dial Transplant 2001; 16: 1402-1408
6. + monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis. Infect Immun 1998; 66: 2782-2790
7. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5: 953-964
8. Ulrich C, Heine GH, Garcia P et al. Increased expression of monocytic angiotensin converting enzyme in dialysis patients with cardiovascular disease. Nephrol Dial Transplant 2006; 21: 1596-1602
9. Heine GH, Ulrich C, Seibert E et al. CD14(++)CD16(+) monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int 2008; 73: 622-629
10. Moreno PR, Falk E, Palacios IF et al. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 1994; 90: 775-778
11. Ribichini F, Pugno F, Ferrero V et al. Cellular immunostaining of angiotensin-converting enzyme in human coronary atherosclerotic plaques. J Am Coll Cardiol 2006; 47: 1143-1149
12. Diet F, Pratt RE, Berry GJ et al. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 1996; 94: 2756-2767
13. Rajagopalan S, Kurz S, Munzel T et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996; 97: 1916-1923
14. Maguire GA, Price CP. A continuous monitoring spectrophotometric method for the measurement of angiotensin-converting enzyme in human serum. Ann Clin Biochem 1985; 22: 204-210
15. U.S. Renal Data System. USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2005;
16. ++ monocytes are a major source of TNF. J Immunol 2002; 168: 3536-3542
17. Mobley JL, Leininger M, Madore S et al. Genetic evidence of a functional monocyte dichotomy. Inflammation 2007; 30: 189-197
18. Sunderkotter C, Nikolic T, Dillon MJ et al. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol 2004; 172: 4410-4417
19. Auffray C, Fogg D, Garfa M et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007; 317: 666-670
20. Tacke F, Alvarez D, Kaplan TJ et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 2007; 117: 185-194
21. Jonasson L, Holm J, Skalli O et al. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986; 6: 131-138
22. Ohishi M, Ueda M, Rakugi H et al. Enhanced expression of angiotensin-converting enzyme is associated with progression of coronary atherosclerosis in humans. J Hypertens 1997; 15: 1295-1302
23. Griendling KK, Minieri CA, Ollerenshaw JD et al. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74: 1141-1148
24. Hayek T, Attias J, Coleman R et al. The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice. Cardiovasc Res 1999; 44: 579-587 25.
25. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000; 105: 1605-1612